EUVIMEDEUVIMED entdecken
Crossref

ROS-responsive mPEG-PCL nanoparticles for co-delivery of paclitaxel prodrug and R848 in synergistic chemo-immunotherapy

Qi Zhang, Luyao Wang, Zhaofan Yang, Hao Meng, Shixian Lv, Linlin Liu

Biomaterials Science · 2026

DOI: 10.1039/d5bm01811k ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Science, 2026. Verfasst von Qi Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, The Second Hospital of Jilin University, Changchun, Jilin, 130041, China. Hauptthemen laut MEDLINE: Paclitaxel, Nanoparticles, Prodrugs, Polyethylene Glycols. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Key Technologies Research and Development Program, National Natural Science Foundation of China, Jilin University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ROS-responsive mPEG-PCL co-delivers PTX-PBE and R848 for immune synergy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelNanoparticlesProdrugsPolyethylene GlycolsReactive Oxygen SpeciesPolyestersImidazolesHumansAnimalsImmunotherapyCell Line, TumorToll-Like Receptor AgonistsMiceDendritic Cells

Substanzen

PaclitaxelProdrugsPolyethylene GlycolsReactive Oxygen SpeciesPolyestersImidazolesresiquimodmethoxy poly(ethylene glycol-co-epsilon-caprolactone)Toll-Like Receptor Agonists

Autor:innen und Institutionen

  • Department of Radiotherapy, The Second Hospital of Jilin University, Changchun, Jilin, 130041, China.
  • Department of Radiation Oncology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, 130033, China. liulinl@jlu.edu.cn.
  • Key Laboratory of Polymer Chemistry and Physics of Ministry of Education, School of Materials Science and Engineering, Peking University, Beijing, 100871, China. lvshixian@pku.edu.cn.

Förderung

  • Key Technologies Research and Development Program
  • National Natural Science Foundation of China
  • Jilin University
  • Department of Science and Technology of Jilin Province
  • Jilin Province Development and Reform Commission
  • Henan Technical Innovation Guidance Projects

Zitieren

APA

Zhang, Q., Wang, L., Yang, Z., Meng, H., Lv, S., & Liu, L. (2026). ROS-responsive mPEG-PCL nanoparticles for co-delivery of paclitaxel prodrug and R848 in synergistic chemo-immunotherapy. Biomaterials Science. https://doi.org/10.1039/d5bm01811k

Vancouver

Zhang Q, Wang L, Yang Z, Meng H, Lv S, Liu L. ROS-responsive mPEG-PCL nanoparticles for co-delivery of paclitaxel prodrug and R848 in synergistic chemo-immunotherapy. Biomaterials Science. 2026. doi:10.1039/d5bm01811k

BibTeX
@article{Zhang2026,
  author = {Zhang, Qi and Wang, Luyao and Yang, Zhaofan and Meng, Hao and Lv, Shixian and Liu, Linlin},
  title = {ROS-responsive mPEG-PCL nanoparticles for co-delivery of paclitaxel prodrug and R848 in synergistic chemo-immunotherapy},
  journal = {Biomaterials Science},
  year = {2026},
  doi = {10.1039/d5bm01811k}
}
Kostenlos starten →